Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares (IINN)

Frequently Asked Questions About Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares (IINN)

How can investors get involved with Inspira Technologies?

Investors interested in Inspira Technologies can become involved by purchasing shares through public stock exchanges like Nasdaq where the company is listed under the ticker symbol IINN. Potential investors should also conduct research on the company's financial health, growth prospects, and market position before making investment decisions.

How does Inspira Technologies approach research and development?

Inspira Technologies adopts a comprehensive approach to research and development by emphasizing clinical research, technology advancement, and user feedback. Their R&D team collaborates closely with medical experts to identify unmet needs in respiratory care, enabling the development of products that are not only innovative but also practical and effective.

How does Inspira Technologies educate healthcare providers about its products?

Inspira Technologies invests in educational initiatives to ensure healthcare providers are well-informed about its products and their applications. This includes conducting training sessions, workshops, and webinars aimed at demonstrating the benefits and functionality of their oxygen delivery systems. The company also provides comprehensive support materials and resources for practitioners.

How does Inspira Technologies ensure product quality?

Inspira Technologies places a strong emphasis on quality assurance in its product development process. The company adheres to strict regulatory standards and protocols, including ISO certifications and Good Manufacturing Practices (GMP). Continuous testing and validation of its products are conducted to ensure they meet the highest safety and efficacy standards for patient care.

How does Inspira Technologies monitor industry trends?

Inspira Technologies actively monitors industry trends through market research, engagement with healthcare professionals, and participation in medical conferences and expos. This continuous engagement helps them stay informed about the latest technological advancements, regulatory changes, and shifting healthcare needs, allowing the company to adapt its strategies accordingly.

Is Inspira Technologies publicly traded?

Yes, Inspira Technologies is publicly traded on the Nasdaq under the ticker symbol IINN. The company went public to gain access to capital markets, which would enable it to further fund its research and development projects and expand its operational capabilities. Being listed on Nasdaq also provides greater visibility and credibility in the healthcare industry.

What are the company’s growth prospects?

Inspira Technologies has promising growth prospects, fueled by an increasing global demand for advanced respiratory care solutions. The rise in respiratory diseases, especially in light of recent health crises, along with the aging population, creates significant market opportunities. The company’s emphasis on innovation and expanding its product line is expected to play a pivotal role in its growth trajectory.

What are the main applications of Inspira Technologies' products?

Inspira Technologies' products are primarily focused on treating patients with respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and pneumonia. They are designed to provide improved oxygen delivery for patients requiring respiratory support, and can be utilized in emergency settings as well as in long-term treatment plans.

What does Inspira Technologies Oxy B.H.N. Ltd. do?

Inspira Technologies Oxy B.H.N. Ltd. is a medical technology company focused on developing innovative products for the management of respiratory conditions. Specifically, the company specializes in oxygen delivery systems designed to enhance oxygen therapy for patients with respiratory issues. Their flagship product aims to provide non-invasive ventilation solutions that optimize oxygen delivery while minimizing complications associated with traditional methods.

What is the company's approach to sustainability?

Inspira Technologies is committed to sustainability by integrating eco-friendly practices into its operations and product development processes. The company seeks to minimize waste, utilize sustainable materials, and reduce its carbon footprint, aligning its business model with ethical and environmentally responsible standards.

What is the flagship product of Inspira Technologies?

The flagship product of Inspira Technologies is the proprietary Oxygenation Technology designed for upper airway management. This non-invasive therapy aims to enhance oxygenation in patients with respiratory distress. It is distinguished by its user-friendly interface and the capacity to adapt to various clinical settings, making it suitable for both hospital and home use.

What is the regulatory status of Inspira Technologies' products?

Inspira Technologies ensures that its products comply with the necessary regulatory standards for medical devices. This includes obtaining relevant approvals and certifications from health authorities such as the FDA for the U.S. market and CE marking for Europe. The regulatory status allows the company's products to be marketed and used in clinical settings following rigorous evaluation of safety and efficacy.

What is the vision of Inspira Technologies?

The vision of Inspira Technologies is to be a leader in respiratory care innovation, delivering advanced solutions that significantly improve patient outcomes. The company aims to change the way respiratory conditions are managed by focusing on non-invasive technologies that enhance patient experience while ensuring safety and efficiency in treatment protocols.

What markets does Inspira Technologies target?

Inspira Technologies targets global markets with a focus on regions with high incidences of respiratory diseases, including North America, Europe, and parts of Asia. The company aims to expand its market presence worldwide by establishing partnerships with healthcare providers, distributors, and various stakeholders in the medical field.

What partnerships or collaborations does Inspira Technologies have?

Inspira Technologies actively seeks partnerships with various healthcare institutions, technology companies, and research organizations. These collaborations aim to enhance product development, broaden the clinical applications of their technology, and facilitate market entry into new regions. The company’s strategic alliances are essential for driving innovation and ensuring successful product deployment.

When was Inspira Technologies founded?

Inspira Technologies was founded in 2013. The company was established with a vision to revolutionize the field of respiratory care through innovative technology. Since its inception, Inspira has focused on research and development to create solutions aimed at improving the lives of patients with severe respiratory disorders.

Where is Inspira Technologies headquartered?

Inspira Technologies is headquartered in Ra'anana, Israel. The strategic location allows the company to collaborate closely with leading healthcare institutions and innovation hubs in the medical technology field. This facilitates both their research and development initiatives, as well as their outreach to international markets.

Who are the key executives in Inspira Technologies?

Inspira Technologies' leadership team consists of experienced professionals from various sectors including healthcare, technology, and finance. The co-founder, CEO, and other key executives bring extensive expertise in their respective fields, providing strategic guidance and oversight to drive the company’s mission and innovation efforts.

Who comprises Inspira Technologies' target customer base?

The target customer base for Inspira Technologies includes hospitals, clinics, outpatient care centers, and home healthcare providers. The company also focuses on healthcare professionals involved in respiratory therapy, such as pulmonologists, intensivists, and respiratory therapists, as key users of their innovative products.

What is the current price of Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares?

The current price of Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares is 0.6691

When was Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares last traded?

The last trade of Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares was at 3:59 pm EDT on April 2nd, 2025